Article
Homeobox B13 G84E Mutation and Prostate Cancer Risk
8 Dec 2018
Abstract excerpt
BACKGROUND: The homeobox B13 (HOXB13) G84E mutation has been recommended for use in genetic counselling for prostate cancer (PCa), but the magnitude of PCa risk conferred by this mutation is uncertain. OBJECTIVE: To obtain precise risk estimates for mutation carriers and information on how these vary by family history and other factors. DESIGN, SETTING, AND PARTICIPANTS: Two-fold: a systematic review and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
